ESC Heart Failure (Apr 2020)

Double‐chambered right ventricle complicated by hypertrophic obstructive cardiomyopathy diagnosed as Noonan syndrome

  • Masahiro Yamamoto,
  • Seiji Takashio,
  • Naoya Nakashima,
  • Shinsuke Hanatani,
  • Yuichiro Arima,
  • Kenji Sakamoto,
  • Eiichiro Yamamoto,
  • Koichi Kaikita,
  • Yoko Aoki,
  • Kenichi Tsujita

DOI
https://doi.org/10.1002/ehf2.12650
Journal volume & issue
Vol. 7, no. 2
pp. 721 – 726

Abstract

Read online

Abstract We present a case of double‐chambered right ventricle (DCRV) complicated by hypertrophic obstructive cardiomyopathy (HOCM) in KRAS mutation‐associated Noonan syndrome. The diagnosis was incidental and made during diagnostic testing for an intradural extramedullary tumour. Spinal compression, if not surgically treated, may cause paralysis of the extremities. We decided to pursue pharmacological therapy to control biventricular obstructions and reduce the perioperative complication rate. We initiated treatment with cibenzoline and bisoprolol; the doses were titrated according to the response. After 2 weeks, the peak pressure gradient of the two RV chambers decreased from 101 to 68 mmHg, and the LV peak pressure gradient decreased from 109 to 14 mmHg. Class 1A antiarrhythmic drugs and β‐blockers decreased the severe pressure gradients of biventricular obstructions caused by DCRV and HOCM. The patient was able to undergo surgery to remove the intradural extramedullary tumour, which was diagnosed as schwannoma.

Keywords